EUCTR2019-004455-36-FR
Active, not recruiting
Phase 1
Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients. - ATO-TS
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- CHU DE POITIERS
- Enrollment
- 45
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients: Tourette’s patients from 10 to 35 years old diagnosed according to the criteria of DSM\-V, with high impulsive trait, and who freely consent to this study
- •Healthy subjects, of normal development, free from any neuropsychiatric pathology, matched 1:1 in age and sex to the patients recruited in this study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 20
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Other psychiatric disease of the axis I of DSM\-IV, severe depression, allergic reactions to chemical coumpounds of the treatment or medical contraindications of atomoxetine, concommitent treatments contraindicated with atomoxetine (IMAO) interrupted from less tha 2 weeks or Clonidine or Methyphenidate interrupted from less than 1 month
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Atomoxetine for cognitive impairment in Behcet's diseaseIRCT20211206053288N1Tehran University of Medical Sciences40
Recruiting
Phase 2
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
Completed
Phase 3
Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncopeIRCT20180125038507N1Tehran University of Medical Sciences50
Recruiting
Phase 2
Effectiveness of Atomoxetine treatment for methamphetamine use disorderOther stimulants dependence syndrome.Dependence syndrome: A cluster of behavioral, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despiteF15.24IRCT2017070234844N1Tehran University of Medical Sciences (TUMS), Vice-chancellor for Research90
Active, not recruiting
Not Applicable
An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without comorbid conditions - NDChild or adolescent patients with Attention-Deficit/ Hyperactivity Disorder ADHDMedDRA version: 6.1Level: PTClassification code 10003736EUCTR2005-005701-32-ITELI LILLY300